BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11295616)

  • 1. Sequence databases and microarrays as tools for identifying prostate cancer biomarkers.
    Grouse LH; Munson PJ; Nelson PS
    Urology; 2001 Apr; 57(4 Suppl 1):154-9. PubMed ID: 11295616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High throughput screening and analysis of prostate cancer-related genes through mining databases].
    Wu G; Peng L; Jin FS; Li QS
    Ai Zheng; 2006 May; 25(5):645-50. PubMed ID: 16687091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarrays--identifying molecular portraits for prostate tumors with different Gleason patterns.
    Mendes A; Scott RJ; Moscato P
    Methods Mol Med; 2008; 141():131-51. PubMed ID: 18453088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of gene microarrays in the study of prostate cancer.
    Nelson CC; Hoffart D; Gleave ME; Rennie PS
    Methods Mol Med; 2003; 81():299-320. PubMed ID: 12725128
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tissue microarrays. High-throughput procedures to verify potential biomarkers].
    Kuefer R; Hofer MD; Gschwend JE; Rubin MA
    Urologe A; 2004 Jun; 43(6):659-67. PubMed ID: 15107975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide gene expression analysis of prostate carcinoma.
    Gerald WL
    Semin Oncol; 2003 Oct; 30(5):635-48. PubMed ID: 14571411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer expression profiling by cDNA sequencing analysis.
    Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L
    Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
    Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
    JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of prognostic biomarkers in prostate cancer.
    Dhanasekaran SM; Barrette TR; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta KJ; Rubin MA; Chinnaiyan AM
    Nature; 2001 Aug; 412(6849):822-6. PubMed ID: 11518967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEDB: the Prostate Expression Database.
    Hawkins V; Doll D; Bumgarner R; Smith T; Abajian C; Hood L; Nelson PS
    Nucleic Acids Res; 1999 Jan; 27(1):204-8. PubMed ID: 9847181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
    Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
    Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium.
    Lin B; White JT; Ferguson C; Wang S; Vessella R; Bumgarner R; True LD; Hood L; Nelson PS
    Cancer Res; 2001 Feb; 61(4):1611-8. PubMed ID: 11245473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel methods to identify biologically relevant genes for leukemia and prostate cancer from gene expression profiles.
    Chen AH; Tsau YW; Lin CH
    BMC Genomics; 2010 Apr; 11():274. PubMed ID: 20433712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents.
    Williams ED; Brooks JD
    Urology; 2001 Apr; 57(4 Suppl 1):100-2. PubMed ID: 11295605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analyses of prostate gene expression: convergence of expressed sequence tag databases, transcript profiling and proteomics.
    Nelson PS; Han D; Rochon Y; Corthals GL; Lin B; Monson A; Nguyen V; Franza BR; Plymate SR; Aebersold R; Hood L
    Electrophoresis; 2000 May; 21(9):1823-31. PubMed ID: 10870968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel gene expression in paraffin-embedded tissues by isotopic in situ hybridization in tissue microarrays.
    Frantz GD; Pham TQ; Peale FV; Hillan KJ
    J Pathol; 2001 Sep; 195(1):87-96. PubMed ID: 11568895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic aspects of prostate transition zone lesions.
    Pavelić J; Zeljko Z; Bosnar MH
    Urology; 2003 Oct; 62(4):607-13. PubMed ID: 14550426
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression profiling using cDNA microarrays.
    Duggan DJ; Bittner M; Chen Y; Meltzer P; Trent JM
    Nat Genet; 1999 Jan; 21(1 Suppl):10-4. PubMed ID: 9915494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
    Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
    BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.